The Nigerian Pharmaceutical Supply Chain: Blockchain Adoption, Counterfeit Drugs and Successful Deployment of COVID-19 Vaccine in Nigeria

Main Article Content

Muhammad Jameel Labaran
Mansur Hamma-Adama


Aim: Critically investigating the possibility of adopting blockchain technology within the Nigerian pharmaceutical supply chain to curb the supply of counterfeit drugs.

Study Design: The study is qualitative in nature and the primary data were fetched through interviews.

Place and Duration of the Study: Conducted within Nigeria for a period of 3 months.

Methodology: A qualitative method of data collection was adopted in the study, where some stakeholders were interviewed. The interviews were conducted with employees from different pharmaceutical companies and some drug regulatory agencies in Nigeria.

Result: Firstly, this study has ascertained the current prevalence of counterfeit drugs and the reasons for that. The study discovers a very high level of counterfeit drugs and some reasons behind that. Secondly, this study has also found some barriers to blockchain adoption, including the fact that the level of awareness of blockchain technology among stakeholders within the Nigerian pharmaceutical supply chain and the regulatory agencies is very low.

Conclusion: It was concluded that the efforts put in developing a viable COVID-19 vaccine could be undermined due to the current nature of the Nigerian pharmaceutical supply chain, the nature of porous borders in place, absence of an apparent drug distribution system, among others.  This study also concludes that the supply chain's current structure needs more regulatory and structural interventions by the Nigerian government than blockchain technology. In other words, with the current nature of the supply chain, blockchain technology adoption would not be effective in delivering the said benefits reported by scholars because the atmosphere is not conducive for successful blockchain adoption.

Blockchain adoption, counterfeit drugs, COVID-19 vaccine, Nigeria, supply chain

Article Details

How to Cite
Labaran, M. J., & Hamma-Adama, M. (2021). The Nigerian Pharmaceutical Supply Chain: Blockchain Adoption, Counterfeit Drugs and Successful Deployment of COVID-19 Vaccine in Nigeria. Journal of Scientific Research and Reports, 27(2), 20-36.
Original Research Article


Blome C, Schoenherr T, Eckstein D. The impact of knowledge transfer and complexity on supply chain flexibility: A knowledge-based view. International Journal of Production Economics. 2014;147:307-16.

Van Kralingen B. How block chain could help to make the food we eat safer around the world. [online]. Forbes; 2016.
Available: [Accessed 8 March 2020].

Azzi R, Chamoun RK, Sokhn M. The power of a block chain-based supply chain. Computers & Industrial Engineering. 2019;135:582-92.

Halabi SF, Gostin LO. Falsified and substandard medicines in globalized pharmaceutical supply chains: Toward actionable solutions. In Food and Drug Regulation in an Era of Globalized Markets. Academic Press. 2015;51-61.

Adsul KB, Kosbatwar SP. A novel approach for traceability & detection of counterfeit medicines through blockchain. EasyChair; 2020;4.

Raj R, Rai N, Agarwal S. Anti counterfeiting in pharmaceutical supply chain by establishing proof of ownership. In TENCON 2019-2019 IEEE region 10 conference (TENCON). IEEE. 2019;1572-1577.

Woosley RL, Schwartz PJ. Counterfeit drugs: A plot worthy of John le Carrè. International Journal of Cardiology. 2017;243:279-80.

Mhando L, Jande MB, Liwa A, Mwita S, Marwa KJ. Public awareness and identification of counterfeit drugs in Tanzania: A view on anti malarial drugs. Advances in Public Health. 2016;2016.

Seiter A. Health and economic consequences of counterfeit drugs. Clinical Pharmacology and Therapeutics. 2009;85(6):576-578.

Aminu NA, Gwarzo MS. The eminent threats of counterfeit drugs to quality health care delivery in Africa: Updates on consequences and way forward. Asian J Pharm Clin Res. 2017;10(7):82-6.

Enyinda CI, Tolliver D. Taking counterfeits out of the pharmaceutical supply chain in Nigeria: Leveraging multilayer mitigation approach. Journal of African Business. 2009;10(2):218-34.

Fatokun O. Curbing the circulation of counterfeit medicines in Nigeria. The Lancet. 2016;388(10060):2603.

Hughes A, Park A, Kietzmann J, Archer-Brown C. Beyond bitcoin: What block chain and distributed ledger technologies mean for firms. Business Horizons. 2019;62(3):273-81.

Min H. Blockchain technology for enhancing supply chain resilience. Business Horizons. 2019;62(1):35-45.

Alzahrani N, Bulusu N. Block-supply chain: A new anti-counterfeiting supply chain using NFC and block chain. In Proceedings of the 1st Workshop on Crypto Currencies and Block Chains for Distributed Systems. 2018;30-35.

Yeung R, Yee WM. Food safety concern. British Food Journal; 2012.

Olapegba PO, Ayandele O, Kolawole SO, Oguntayo R, Gandi JC, Dangiwa AL, et al. A preliminary assessment of novel corona virus (COVID-19) knowledge and perceptions in Nigeria; 2020.

Yamey G, Schäferhoff M, Hatchett R, Pate M, Zhao F, Mc Dade KK. Ensuring global access to COVID-19 vaccines. The Lancet. 2020;395(10234):1405-6.

Cohen Jon. Vaccine designers take first shots at COVID-19. 2020:14-16.

Peeples L. News feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine. Proceedings of the National Academy of Sciences. 2020;117(15):8218-21.

NCDC COVID-19 Nigeria. ; 2020.

Olatunji H. Corona virus: Catholic church in lagos suspends sprinkling of ‘holy water’, handshakes during mass. Covid-19 Knowledge and Perceptions In Nigeria; 2020.

Abati R. Corona Blues; 2020.

Soludo; 2020.

Hotez PJ, Bottazzi ME. Developing a low-cost and accessible COVID-19 vaccine for global health. PLoS Neglected Tropical Diseases. 2020;14(7):e0008548.

Adepoju P. Tuberculosis and HIV responses threatened by COVID-19. The Lancet HIV. 2020;7(5):e319-20.

Reuben RC, Danladi MM, Pennap GR. Is the COVID-19 pandemic masking the deadlier lassa fever epidemic in Nigeria?. Journal of Clinical Virology. 2020;128:104434.

Oladele TT, Olakunde BO, Oladele EA, Ogbuoji O, Yamey G. The impact of COVID-19 on HIV financing in Nigeria: A call for proactive measures. BMJ Global Health. 2020;5(5):e002718.

Klantschnig G, Huang C. Fake drugs: Health, wealth and regulation in Nigeria. Review of African Political Economy. 2019;46(161):442-58.

Onyebuchi OB. National drug distribution in Nigeria. Implications for the goals of national drug policy. Eur J Pharm Med Res. 2016;3(1):1-4.

Webb S. A bitter pill to swallow: The problem of, and solutions to, Sub-Saharan Africa’s counterfeit pharmaceutical trade. The Columbia Journal of Global Health. 2014;4(2):19-25.

Newton PN, Green MD, Fernández FM, Day NP, White NJ. Counterfeit anti-infective drugs. The Lancet Infectious Diseases. 2006;6(9):602-13.

Bate R. Making a killing: The deadly implications of the counterfeit drug trade. American Enterprise Institute; 2008.

Bird RC. Counterfeit drugs: A global consumer perspective. Wake Forest Intell. Prop. LJ. 2007;8:387.

Akiny O. Counterfeit drugs in Nigeria: A threat to public health. African Journal of Pharmacy and Pharmacology. 2013;7(36):2571-6.

Blackstone EA, Fuhr Jr JP, Pociask S. The health and economic effects of counterfeit drugs. American health and drug benefits. 2014;7(4):216.

Ubajaka CF, Obi-Okaro AC, Emelumadu OF, Azumarah MN, Ukegbu AU, Ilikannu SO. Factors associated with drug counterfeit in Nigeria: A twelve year review. Journal of Advances in Medicine and Medical Research. 2016;1-8.

Mackey TK, Nayyar G. A review of existing and emerging digital technologies to combat the global trade in fake medicines. Expert Opinion on Drug Safety. 2017;16(5):587-602.

Clauson KA, Breeden EA, Davidson C, Mackey TK. Leveraging block chain technology to enhance supply chain management in healthcare. Block Chain in Healthcare Today; 2018.

Wahyuni D. The research design maze: Understanding paradigms, cases, methods and methodologies. Journal of Applied Management Accounting Research. 2012;10(1):69-80.

Saunders M, Tosey PC. The layers of research design. Rapport, (Winter). 2013;58-59.

Saunders M, Lewis P, Thornhill A. Research methods for business students. Essex: Prentice Hall: Financial Times; 2003.

Wedawatta G, Ingirige M, Amaratunga R. Case study as a research strategy: Investigating extreme weather resilience of construction SMEs in the UK; 2011.

Moriarty J. Qualitative methods overview; 2011.

Collis J, Hussey R. Business research: A practical guide for undergraduate and postgraduate students. Macmillan International Higher Education; 2013.

Muzaimi M, Chew B. Accreditation for quality management system: A case study of integrated management system in AUO sun power. (ICTMBE 2013 International Conference on Technology Management, Business and Entrepreneurship Melaka 4-5 December). Melaka: International Conference on Technology Management, Business and Entrepreneurship; 2013.

Parker LD. Qualitative research in accounting and management: The emerging agenda; 2013.

Sekaran U, Bougie R. Research methods for business: A skill building approach. John Wiley & Sons; 2016.

Yin RK. Case study research: Design and methods fourth edition. Los Angeles and London: SAGE; 2009.

Mc Namara C. General guidelines for conducting interviews; 1999.

Gall MD, Borg WR, Gall JP. Educational research: An introduction. Longman Publishing; 1996.

Turner III DW. Qualitative interview design: A practical guide for novice investigators. The Qualitative Report. 2010;15(3):754.

Bansal D, Malla S, Gudala K, Tiwari P. Anti-counterfeit technologies: A pharmaceutical industry perspective. Scientia pharmaceutica. 2013;81(1):1-4.

Chang SE, Chen YC, Lu MF. Supply chain re-engineering using block chain technology: A case of smart contract based tracking process. Technological Forecasting and Social Change. 2019;144:1-1.

Montecchi M, Plangger K, Etter M. It’s real, trust me! Establishing supply chain provenance using block chain. Business Horizons. 2019;62(3):283-93.